Patent · US Active

Methods for treating lung disorders

US11160754B2 · kind B2 · utility

0Cited by
56References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2019
Grant dateNov 2, 2021
Priority date
Expiry dateOct 31, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are compositions and methods for treating lung disorders including lung tumors by pulmonary administration of compositions comprising taxane particles such as docetaxel or paclitaxel particles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.